We will improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company. Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here for our Global Vision.
Inspiration - special one-off magazine dedicated to Idiopathic Pulmonary Fibrosis. Produced in partnership with Action for Pulmonary Fibrosis and the British Lung Foundation.
Learn more about Pharmaphorum and Boehringer Ingelheim's White paper
Facts about us
We are one of the top 20 leading pharmaceutical companies in the world.
In 2014, worldwide, we had sales of €13.3 billion; while spending 19.9% of net sales in our largest business segment Prescription Medicines on research and development.
Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease, cerebrovascular disease, diabetes and oncology.